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INTRODUCTION
Band keratopathy, first described by Bowman in 1849 (1)
may occur secondary to chronic ocular inflammatory condi-
tions such as anterior uveitis and dry eye syndrome. Long-term
use of eye drops containing mercury, and some inherited con-
ditions or systemic diseases associated with hypercalcemia
such as chronic renal failure and bone destruction disorders
also are common causes of corneal calcified lesions (2-4). De-
posited calcium band is observed horizontally on the cornea
and there is lesion free, lucid space between the limbus and
lesion. It may cause blindness as the result of opacification of
the cornea, block the visual axis and cause pain due to corneal
epithelial erosions (2-4). Impacted calcium is mainly found at
the level of the corneal epithelium, but in some cases, the base-
ment membrane was destroyed and calcium deposition invad-
ed the anterior stroma beneath Bowman’s membrane. Based
on the extent of basement membrane destruction and stro-
mal invasion, band keratopathy can be divided into two sub-
types: a superficial type that includes epithelial layer involve-
ment, and a deep type where calcium is situated under Bow-
man’s layer, and even involves the stromal layer. Convention-
al treatments have focused on only the removal of deposited
calcium by superficial keratectomy, ethylenediaminetetraacetic
acid (EDTA) treatment, or excimer laser phototherapeutic
keratectomy (PTK) (5-10). The aim of these treatments was
to remove the calcium impaction in the epithelial layer. These
conventional treatments failed to completely remove the
deeply situated calcium plaque. So, new treatment methods
must be developed to completely remove deep-impacted cal-
cium without any sequela, and allow no recurrence. 
Amniotic membrane has many unique characteristics and
it facilitates wound healing, stabilizes the ocular surface and
enhances corneal re-epithelialization. Amniotic membrane
transplantation (AMT) was recently reintroduced into oph-
thalmology (11), and has been successfully used for ocular
surface reconstruction, notably facilitating epithelialization,
as well as suppression of ocular surface inflammation, neovas-
cularization, and scarring in the stroma (12-22). In addition,
during the wound healing process, amniotic membrane acts
as a temporary dressing to protect the corneal surface, absorbs
inflammatory cytokines, and reduces pain during corneal epi-
thelialization. 
We report two cases of deep-type band keratopathy treated
with AMT following EDTA chelation with trephination and
blunt superficial lamellar keratectomy in the anterior stromal
layer. 
CASE REPORT
Case 1
A 64-yr-old female patient with calcified corneal lesions on
the cornea was referred to Chung-Ang University Hospital.
She had a history of extracapsular cataract extraction and in-
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New Treatment for Band Keratopathy: Superficial Lamellar Keratectomy,
EDTA Chelation and Amniotic Membrane Transplantation
We report two cases of band keratopathy who were treated with thick amniotic mem-
brane that contained a basement membrane structure as a graft, after ethylenedi-
aminetetraacetic acid chelation with trephination and blunt superficial lamellar ker-
atectomy in the anterior stroma. In each case, basement membrane was destroyed
and calcium plaque invaded into anterior stroma beneath Bowman’s membrane. The
calcified lesions were removed surgically, resulting in a smooth ocular surface, and
the fine structures of band keratopathy were confirmed by pathologic findings. After
that, amniotic membrane transplantation was performed to replace the excised epithe-
lium and stroma. Wound healing was completed within 10 days. Stable ocular sur-
face was restored without pain or inflammation. During the mean follow-up period
of 13.5 months, no recurrence of band keratopathy was observed. This combined
treatment is a safe and effective method for the removal of deep-situated calcium
plaque and allowing the recovery of a stable ocular surface.
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traocular lens (IOL) implantation in the left eye 20 yr ago.
Recently, the patient’s visual condition was aggravated in
both eyes, after the first ocular surgery. Corneal opacity had
continued to progress and foreign body sensation and blur-
ring had developed in both eyes over the past 10 yr. Slit lamp
examination revealed corneal opacity, and calcium plaque (Fig.
1A), but limbal deficiency was not observed. She had light
perception vision and intraocular pressures, that were checked
by Pro-view
� (BAUSCH & LOMB, Tampa, FL, U.S.A.) were
in normal ranges in both eyes. Serum levels of Ca++, BUN,
and creatinine were all normal (8.7, 13, and 0.9 mg/dL, respec-
tively). The diagnosis of band keratopathy, pseudophakia and
Vogt-Koyanaki-Harada syndrome was made.
The patient underwent surgery to remove the calcified band
keratopathy. First, trephination to the anterior stromal layer
was performed by using 6 mm size punch (Stortz, Denver, CO,
U.S.A.) in both eyes. Then EDTA (0.125 M) was applied for
2.5 min until it adequately infiltrated the space between the
destroyed stroma and dissolved the calcium impaction. Then,
the superficial keratectomy with a round blade and #15-0
Bard-Parker blade was done and the transplantation of the
basement membrane-containing thick amniotic membrane
(preserved in DMEM and glycerol 2:1 mixed media, -70℃)
was performed epithelial side up. Amniotic membrane was
sutured into place using interrupted and continued bite sec-
ondary with #10-nylon for replacement of the defective stro-
ma. Subsequently, the temporary amniotic membrane patch
(TAMP) with epithelial side down was done to protect the
ocular surface.
Postoperatively, the patient was treated with 20% autolo-
gous serum and ofloxacin (Tarivid
�, Santen, Osaka, Japan) 4
times a day from the second day after the operation. On the 5th
post-operative day, neomycin/polymixin-B/dexamethasone
mixed eye drops (Maxitrol
�, Alcon, Ft. Worth, TX, U.S.A.)
were administered for 3 days and then changed to flourome-
thorone (Ocumethrone
�, Shin-Il, Seoul, Korea) for 2 weeks.
After removal of TAMP on the 5th day, the epithelium was
healed to a pinpoint-like defect in the right eye and one-third
part of a defect in the left eye upon slit lamp examination.
The patient did not complain of any ocular pain, but only
did foreign body sensation. Corneal epithelialization was con-
firmed on the 2nd postoperation day, and when completed,
the ocular surface was stable in the both eyes on the 10th post-
operation day. Pathologic findings of biopsy specimen revealed
impacted calcium in the epithelium and anterior stroma. De-
stroyed basement membrane and superficial stromal degen-
eration were also observed in the electron micrographic figure
(Fig. 1C). After discharge, during outpatient department
follow up, the patient did not complain of ocular pain but
only the condition of cornea remained stable. On the last fol-
Fig. 1. (A) Calcium is deposited on the cornea (visual acuity: light
perception). (B) Multiple calcium impactions and calcium deposit
are observed in the stromal layer (H&E, ×200). (C) Deposited
calcium is seen in stromal layer (asterisk). Destroyed basement
membrane is observed in the degenerated stromal space (arrow)
(×4,100).
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*low up after 17 months, visual acuity had improved to fin-
ger count at 70 cm, and intraocular pressure was 10/12 torr
in both eyes. Macular degenerations and hypertensive retino-
pathy (Keith-Wagener, grade 2) were observed in the both
eyes. Because of these lesions, visual outcome was poor in
spite of the removal of calcified lesions with stabilized corneal
surface. 
Case 2
A 60-yr-old male patient visited our clinic because of ocu-
lar pain and severe foreign body sensation in the right eye.
He had undergone intra-capsular cataract extraction and ante-
rior chamber lens (ACL) implantation in the right eye under
diagnosis of presenile cataract 19 yr ago. Severe pain and blur-
ring had developed since the 8 yr after the operation; and
symptoms had been increasingly exacerbated thereafter. Visual
acuity was perceptive to hand motion in the involved right
eye and 0.9 in the normal left eye. Slit lamp examination
revealed corneal opacity and horizontal calcified corneal lesions
in the palpebral fissure. Partial limbal deficiency and pseu-
dopterygium with neovascularization were also seen at the 4
o’clock position (Fig. 2A). Because of calcified corneal lesions,
it was impossible to examine full details, but a dislocated
anterior chamber lens (ALC) and iridotomy hole on the periph-
eral iris in the anterior chamber. Intraocular pressures (IOP)
were measured at the level of 33 torr in the right side and
20 torr in the left eye by Pro-view
�. Serum levels of Ca++,
BUN, and creatinine were in normal ranges (8.5, 14 and 1.1
mg/dL, respectively) and no systemic disorders were found.
We diagnosed him as ACL dislocation, secondary glaucoma,
and possibly anterior uveitis and band keratopathy. Patient
was given -blocker and carbonic anhydrase inhibitor mixed
eye drop (Cosopt
�, MSD, Whitehouse Station, NJ, U.S.A.)
twice a day, acetzolamide 250 mg (Diamox
�, Wyeth, Madi-
son, NJ, U.S.A.), twice a day, p.o. for IOP control. After con-
firming the normalized IOP, the patient underwent trephi-
nation with 6 mm size punch into the potent pathologic space
beneath Bowman’s layer to instill EDTA. After that, EDTA
chelation (0.125 M) to dissolve the calcium plaque was per-
formed for 2.5 min until enough had spread into the space.
Then, superficial keratectomy with blunt spatula was done
without any excision or scraping, because the instilled EDTA
had already dissolved the calcium impaction and the space
between the destroyed stroma and Bowman’s membrane had
separated clearly without any scar. After removal of pseu-
dopterygium and ACL, AMT was performed with epithe-
lial side up to replace the removed stromal matrix and enhance
wound healing. Then, TAMP with epithelial side down was
done under local anesthesia. Amniotic membrane graft was
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Fig. 2. (A) Calcified plaque and pseudopterygium is seen (arrow)
(visual acuity: perceptive to hand motion). (B) On postoperative 4
months, permanent amniotic membrane graft and clear cornea is
seen. (C) Impacted calcium was seen over (arrow) and below
(arrow head) the Bowman’s membrane. And degenerated and
destroyed stroma was observed (asterisk). (H&E, ×200).
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sutured in place interruptedly and continuously with #10-0
nylon after removal of the calcium-impacted epithelium and
anterior stroma. IOL re-implantation was not done. Postop-
eratively, the patient was treated with the same drug regimen
as described in case 1. On the 2nd day, corneal reepithelial-
ization had started and was nearly completed after 9 days.
When discharged on the 12th day, the visual outcome was
noted at finger count of 60 cm and the IOP was 9 torr under
aphakic conditions by Pro-view
�. Pathologic findings of the
cornea showed impacted calcium, broken basement mem-
brane and separated Bowman’s membrane due to calcium
deposition with degenerative changes (Fig. 2C). The pain
and severe inflammation were not revealed until the last fol-
low up at 10 months after the operation. Final visual outcome
was recorded as 0.06 in the right eye with aphakic state and
the corrected visual acuity was 0.4.
DISCUSSION
Calcified band keratopathy is characterized by a grayish-
white opacity of the superficial cornea, usually in the inter-
palpebral area. By pathologic findings, band keratopathy is
divided into two different subtypes according to the calcium-
impacted layer. In the superficial type, calcium is scattered
only in the epithelium and the basement membrane is pre-
served intact; in the deep type, however, calcium plaque in-
vades the anterior stroma beyond Bowman’s membrane and
the basement membrane is destroyed, and a potent space is
observed. In the cases in our report, broad and diffuse calci-
fications as confirmed by pathologic examination, invaded
the stromal layer under the basement membrane (Fig. 1B,
C, 2C). The treatment of band keratopathy has a purpose of
removing the calcified plaque deposition and restoring the
smooth corneal surface. In applying conventional techniques,
however, several complications appeared, including severe
pain, low visual acuity, and recurrence. Because these treat-
ments mainly focused on the removal of superficial calcium
deposits in the epithelial layer (5-10), the calcium plaque
impacted in the stromal layer was unable to be removed com-
pletely. For complete removal of calcium deposits and to pre-
vent recurrence, treatment must be modified according to
the subtype. We reported the present cases to demonstrate a
new strategy in the management of deep-situated calcium
band keratopathy by combining EDTA chelation with trephi-
nation and blunt superficial lamellar keratectomy without
excision followed by thick amniotic membrane transplanta-
tion for the complete removal of impacted calcium in stromal-
deposited deep subtype. We trephined the cornea enough to
facilitate the infiltration of the EDTA solution, and after that,
we removed the calcified plaque by blunt spatula to permit
a clear, smooth surface without any scraping (the second case).
In the first case, we used a round blade and #15-0 Bard-Park-
er blade, so stromal scarring could potentially remain. By
trephining enough into the stromal layer, EDTA was instilled
into the pathologic potent space between the destroyed stro-
ma by calcium plaque, and dissolved them. So, without any
scraping, the calcified lesions were separated clearly and the
smooth surface was preserved without scarring. This tech-
nique could restore an intact corneal surface after wound heal-
ing, with minimal refractive error or discomfort to patients. 
Amniotic membrane provides a thick basement membrane
and avascular stroma that replaces the removed tissue, and
has been reported to facilitate corneal and conjunctival epithe-
lialization both in vivo and in vitro (12-19). In our surgical
method, calcified lesions were removed completely, but the
relatively deep corneal stromal defect could potentially delay
wound healing. So, to promote wound healing, we replaced
the corneal defect with thick amniotic membrane that con-
tains the basement membrane structure. Anderson et al. (10)
reported that patients had a mean epithelial healing time of
15.2 days (7-60 days) and no pain or recurrence after AMT
for mean follow up period of 14.6 months. Similarly, we ob-
served complete re-epithelialization of the eye after 9-10 days,
with a stable, smooth corneal surface and without inflam-
mation and discomfort. During the mean follow-up period
of 13.5 months, no patients reported any recurrence of the
ocular surface pain that originally constituted the principal
complaint. The lack of inflammation and the return of corneal
clarity after surgery may be attributed to the complete removal
of calcium without any scarring, and the action of the amni-
otic membrane that replaced the basement membrane and
stromal matrix. Recently, it was reported that an amniotic
membrane matrix can suppress transforming growth factor-
(TGF- ) signaling and the proliferation and myofibroblast
differentiation of normal human corneal and limbal fibrob-
lasts (21). This action helps explain why amniotic membrane
transplantation reduces corneal haze after phototherapeutic
or photorefractive keratectomy in rabbits (19, 22). We have
also used the amniotic membrane in the treatment of other
corneal diseases with epithelial defects. Amniotic membrane
application showed many promising effects on promoting
corneal epithelial healing, maintaining clarity and resulted
in a lower recurrence after the removal of pterygium (18).
In conclusion, we found that amniotic membrane trans-
plantation following EDTA chealation with punch trephi-
nation and blunt superficial lamellar keratectomy was a sim-
ple, safe and effective method to completely remove calcified
lesions, and that amniotic membrane transplantation was
useful to restore a stable ocular surface in band keratopathy. 
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